AbbVie Price Earnings Ratio from 2010 to 2025

ABBV Stock  USD 202.72  1.42  0.71%   
AbbVie Price Earnings Ratio yearly trend continues to be fairly stable with very little volatility. Price Earnings Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, AbbVie Price Earnings Ratio regression line of quarterly data had mean square error of  287.82 and geometric mean of  26.48. View All Fundamentals
 
Price Earnings Ratio  
First Reported
2010-12-31
Previous Quarter
73.32542459
Current Value
76.99
Quarterly Volatility
21.93005801
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Price Earnings Ratio Growth Pattern

Below is the plot of the Price Earnings Ratio of AbbVie Inc over the last few years. It is AbbVie's Price Earnings Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Price Earnings Ratio10 Years Trend
Slightly volatile
   Price Earnings Ratio   
       Timeline  

AbbVie Price Earnings Ratio Regression Statistics

Arithmetic Mean32.18
Geometric Mean26.48
Coefficient Of Variation68.16
Mean Deviation17.91
Median24.18
Standard Deviation21.93
Sample Variance480.93
Range66.7776
R-Value0.66
Mean Square Error287.82
R-Squared0.44
Significance0
Slope3.06
Total Sum of Squares7,214

AbbVie Price Earnings Ratio History

2025 76.99
2024 73.33
2023 56.34
2022 24.18
2021 20.76
2020 38.7
2019 16.64

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Price Earnings Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Earnings Ratio 73.33  76.99 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.